The Early Recognition of Pulmonary Arterial Hypertension
1 other identifier
interventional
52
1 country
1
Brief Summary
The early detection of pulmonary arterial hypertension may help to improve prognosis of the disease. It is assumed that in the early stages of pulmonary arterial hypertension, pulmonary arterial pressure values may be normal at rest, but the remodelling of small arteries leads to stiffening resulting in increased pulmonary arterial pressure during exercise. In the present study we investigate patients with risk factors for pulmonary arterial hypertension (e.g. connective tissue disease) by combining exercise tricuspid echo doppler and cardiopulmonary exercise test to screen patients for exercise-induced pulmonary hypertension and control the results by the gold standard right heart catheterisation at rest and during exercise. We expect that using this screening method, patients with pulmonary arterial hypertension would be recognized earlier.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 24, 2008
CompletedFirst Posted
Study publicly available on registry
February 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedJanuary 12, 2012
January 1, 2012
3.1 years
January 24, 2008
January 11, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pulmonary arterial pressure
measurements with right heart catheterisation within 1 month after exercise tricuspid doppler
Secondary Outcomes (1)
exercise capacity (peakVO2, 6 minute walk distance)
controlled at 1 year after baseline
Study Arms (1)
connective tissue disease
OTHERall patients suffer from a connective tissue disease representing a risk for the development of pulmonary hypertension
Interventions
exercise tricuspid echo doppler (ETED): allows the estimation of systolic pulmonary arterial pressure at exercise cardiopulmonary exercise test (CPET) allows to measures exercise capacity (peakVO2) right heart catheterisation (RHC): is the gold standard for the measurement of pulmonary arterial pressure values
Eligibility Criteria
You may qualify if:
- Systemic sclerosis
- SLE
- Late corrected left-right shunt
- HIV Infection
- Splenectomy over 10 years
- Haemoglobinopathy and Thrombocytosis
- Ventriculo-atrial Shunt
- Liver cirrhosis/other portal Hypertension
- Anamnestic Aminorex or PhenFen abuse
- Close relatives of patients with IPAH
- Healthy controls
You may not qualify if:
- Known PAH
- Severe lung or bronchial disease (FEV1 \<70% predicted)
- Systolic LV dysfunction (LVEF \<50%) or diastolic dysfunction (pulmonary arterial "wedge" pressure (PAWP) ≥15 mmHg)
- Valvular dysfunction \> Grad I (except of Tricuspidal- and Pulmonary insufficiency)
- Uncontrolled systemic arterial hypertension (rest \>150 mmHg systolic or 90 mmHg diastolic; exercise \>220 mmHg systolic)
- Uncontrolled ventricular arrythmia
- Uncontrolled supraventricular arrythmia
- Myocardial infarction within last 12 months
- Pulmonary embolism within last 12 months
- Significant change in therapy or larger operation within last 12 weeks
- Inability of performing exercise on cycle ergometer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Graz, Division of Pulmonology
Graz, Styria, 8036, Austria
Related Publications (2)
Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Troester N, Salmhofer W, Stauber R, Fuerst FC, Thonhofer R, Ofner-Kopeinig P, Gruenig E, Olschewski H. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest. 2010 Aug;138(2):270-8. doi: 10.1378/chest.09-2099. Epub 2010 Apr 23.
PMID: 20418368DERIVEDKovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Troster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med. 2009 Nov 1;180(9):881-6. doi: 10.1164/rccm.200904-0563OC. Epub 2009 Aug 13.
PMID: 19679693DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Horst Olschewski, MD
Medical University of Graz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2008
First Posted
February 7, 2008
Study Start
April 1, 2006
Primary Completion
May 1, 2009
Study Completion
May 1, 2009
Last Updated
January 12, 2012
Record last verified: 2012-01